Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2008

01-06-2008 | Gastrointestinal Oncology

Esophageal Cancers with Synchronous or Antecedent Head and Neck Cancers: A More Formidable Challenge?

Authors: Oswens Siu-Hung Lo, MBBS, FRCS (Edin), Simon Law, MS, MA (Cantab), MBBChir, FRCS(Edin), FACS, William I. Wei, MS, MBBS, FRCS(Edin), FACS, Wai-Man Ng, MS, MBBS, FRCS (Edin), Kam-Ho Wong, MBBS, FRCS(Edin), King-Hung Tong, MBBS, FRACS, John Wong, MD, PhD, FRACS, FACS (Hon)

Published in: Annals of Surgical Oncology | Issue 6/2008

Login to get access

Abstract

Background

The presence of synchronous or antecedent head and neck cancers may complicate management of patients with primary esophageal cancer.

Methods

From January 1982 to December 2004, by means of a prospectively collected database, we compared information from 119 patients with esophageal cancers who had synchronous or antecedent head and neck cancers with information from 1555 patients who only had squamous cell esophageal cancer in a tertiary referral academic hospital.

Results

There were far more men and younger patients in those who had head and neck cancers, and multicentric tumors were also more common. Hypopharyngeal tumors were the most frequently encountered head and neck cancer and were found in 36.1% of patients. Resection rates of the primary esophageal cancers were similar in those who had head and neck cancers and in those who only had esophageal cancer (60.7% vs. 61.7% P = .74). Overall postoperative complication rates were not different. Thirty-day mortality rates were 0% and 2.9% for those who did and did not have head and neck tumors, respectively (P = .25). The respective hospital mortality rates were 10.3% and 9.5% (P = .83). Median survival for resectable esophageal cancers was 9.2 months for the former group and 13.4 months for the latter (P = .02).

Conclusions

Esophagectomy rates did not differ when synchronous or antecedent head and neck cancers were present. Similar postoperative morbidity and mortality rates could be achieved. The presence of additional head and neck tumors imparted a worse long-term prognosis.
Literature
1.
go back to reference Strong M, Incze J, Vaughan L. Field cancerization in the aerodigestive tract—its etiology, manifestation and significance. J Otolaryngol 1984; 13:1–6PubMed Strong M, Incze J, Vaughan L. Field cancerization in the aerodigestive tract—its etiology, manifestation and significance. J Otolaryngol 1984; 13:1–6PubMed
2.
go back to reference Morita M, Saeki H, Mori M, et al. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 2002; 131:S1–6PubMedCrossRef Morita M, Saeki H, Mori M, et al. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 2002; 131:S1–6PubMedCrossRef
3.
go back to reference Murakami S, Hashimoto T, Noguchi T, et al. The utility of endoscopic screening for patients with esophageal or head and neck cancer. Dis Esophagus 1999; 12:186–90PubMedCrossRef Murakami S, Hashimoto T, Noguchi T, et al. The utility of endoscopic screening for patients with esophageal or head and neck cancer. Dis Esophagus 1999; 12:186–90PubMedCrossRef
4.
go back to reference Scherubl H, von Lampe B, Faiss S, et al. Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer 2002; 86:239–43PubMedCrossRef Scherubl H, von Lampe B, Faiss S, et al. Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer 2002; 86:239–43PubMedCrossRef
5.
go back to reference Watanabe A, Hosokawa M, Taniguchi M, et al. Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer. Ann Thorac Surg 2003; 76:1699–705PubMedCrossRef Watanabe A, Hosokawa M, Taniguchi M, et al. Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer. Ann Thorac Surg 2003; 76:1699–705PubMedCrossRef
6.
go back to reference Poon RT, Law SY, Chu KM, et al. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998; 65:1529–34PubMedCrossRef Poon RT, Law SY, Chu KM, et al. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998; 65:1529–34PubMedCrossRef
7.
go back to reference Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932; 51:1358–40 Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932; 51:1358–40
8.
go back to reference Law S, Wong J. Esophagogastrectomy for carcinoma of the esophagus and gastric cardia, and the esophageal anastomosis. In: Fischer JE, Bland KI, eds. Mastery of Surgery. Philadelphia: Lippincott Williams & Wilkinns, 2007; 752–71 Law S, Wong J. Esophagogastrectomy for carcinoma of the esophagus and gastric cardia, and the esophageal anastomosis. In: Fischer JE, Bland KI, eds. Mastery of Surgery. Philadelphia: Lippincott Williams & Wilkinns, 2007; 752–71
9.
go back to reference Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997; 114:210–7PubMedCrossRef Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997; 114:210–7PubMedCrossRef
10.
go back to reference Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993; 113:138–47PubMed Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993; 113:138–47PubMed
11.
go back to reference Law S, Kwong DL, Kwok KF, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238:339–47PubMed Law S, Kwong DL, Kwok KF, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238:339–47PubMed
12.
go back to reference Murthy S, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003; 126:1160–7CrossRef Murthy S, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003; 126:1160–7CrossRef
13.
go back to reference Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000; 12:240–5PubMedCrossRef Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000; 12:240–5PubMedCrossRef
14.
go back to reference Suzuki T, Takahashi H, Yao K, et al. Multiple primary malignancies in the head and neck: a clinical review of 121 patients. Acta Otolaryngol Suppl 2002; 88–92 Suzuki T, Takahashi H, Yao K, et al. Multiple primary malignancies in the head and neck: a clinical review of 121 patients. Acta Otolaryngol Suppl 2002; 88–92
15.
go back to reference Mizobuchi S, Kato H, Tachimori Y, et al. Multiple primary carcinoma of the oesophagus. Surg Oncol 1993; 2:249–53PubMedCrossRef Mizobuchi S, Kato H, Tachimori Y, et al. Multiple primary carcinoma of the oesophagus. Surg Oncol 1993; 2:249–53PubMedCrossRef
16.
go back to reference Qureshi R, Norton R. Squamous cell carcinoma in esophageal remnant after 24 years: lesson learnt from esophageal bypass surgery. Dis Esophagus 2000; 13:245–7PubMedCrossRef Qureshi R, Norton R. Squamous cell carcinoma in esophageal remnant after 24 years: lesson learnt from esophageal bypass surgery. Dis Esophagus 2000; 13:245–7PubMedCrossRef
17.
go back to reference Shiozaki H, Tsujinaka T, Inoue H, et al. Larynx preservation in surgical treatment of cervical esophageal cancer—combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus 2000; 13:213–8PubMedCrossRef Shiozaki H, Tsujinaka T, Inoue H, et al. Larynx preservation in surgical treatment of cervical esophageal cancer—combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus 2000; 13:213–8PubMedCrossRef
18.
go back to reference Burmeister BH, Dickie G, Smithers BM, et al. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 2000; 126:205–8PubMed Burmeister BH, Dickie G, Smithers BM, et al. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 2000; 126:205–8PubMed
19.
go back to reference Guillot T, Spielmann M, Kac J, et al. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas. Laryngoscope 1992; 102:311–9PubMedCrossRef Guillot T, Spielmann M, Kac J, et al. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas. Laryngoscope 1992; 102:311–9PubMedCrossRef
20.
go back to reference Elias D, Cavalcanti A, Dube P, et al. Circumferential pharyngolaryngectomy with total esophagectomy for locally advanced carcinomas. Ann Surg Oncol 1998; 5:511–6PubMedCrossRef Elias D, Cavalcanti A, Dube P, et al. Circumferential pharyngolaryngectomy with total esophagectomy for locally advanced carcinomas. Ann Surg Oncol 1998; 5:511–6PubMedCrossRef
21.
go back to reference Bottger Th, Bumb P, Dutkowski P, et al. Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge. Eur J Surg 1999; 165:940–6PubMedCrossRef Bottger Th, Bumb P, Dutkowski P, et al. Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge. Eur J Surg 1999; 165:940–6PubMedCrossRef
Metadata
Title
Esophageal Cancers with Synchronous or Antecedent Head and Neck Cancers: A More Formidable Challenge?
Authors
Oswens Siu-Hung Lo, MBBS, FRCS (Edin)
Simon Law, MS, MA (Cantab), MBBChir, FRCS(Edin), FACS
William I. Wei, MS, MBBS, FRCS(Edin), FACS
Wai-Man Ng, MS, MBBS, FRCS (Edin)
Kam-Ho Wong, MBBS, FRCS(Edin)
King-Hung Tong, MBBS, FRACS
John Wong, MD, PhD, FRACS, FACS (Hon)
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9860-y

Other articles of this Issue 6/2008

Annals of Surgical Oncology 6/2008 Go to the issue